ABSTRACT
Objectives Interaction between neoplastic and stromal cells plays an important role in tumour progression. It was recently found that WNT2 was frequently overexpressed in fibroblasts isolated from tumour tissue tumour fibroblasts (TF) compared with fibroblasts from non-tumour tissue normal fibroblasts in oesophageal squamous cell carcinoma (OSCC). This study aimed to investigate the effect of TF-secreted Wnt2 in OSCC development via the tumourestroma interaction.
Methods Quantitative PCR, western blotting, immunohistochemistry and immunofluorescence were used to study the expression pattern of Wnt2 and its effect on the Wnt/b-catenin pathway. A Wnt2-secreting system was established in Chinese hamster ovary cells and its conditioned medium was used to study the role of Wnt2 in cell proliferation and invasion.
Results Expression of Wnt2 could only be detected in TF but not in OSCC cancer cell lines. In OSCC tissues, Wnt2 (+) cells were mainly detected in the boundary between stroma and tumour tissue or scattered within tumour tissue. In this study, Wnt2-positive OSCC was defined when five or more Wnt2(+) cells were observed in 2003 microscopy field. Interestingly, Wnt2-positive OSCC (22/51 cases) was significantly associated with lymph node metastases (p¼0.001), advanced TNM stage (p¼0.001) and disease-specific survival (p<0.0001). Functional study demonstrated that secreted Wnt2 could promote oesophageal cancer cell growth by activating the Wnt/b-catenin signalling pathway and subsequently upregulated cyclin D1 and c-myc expression. Further study found that Wnt2 could enhance cell motility and invasiveness by inducing epithelialemesenchymal transition.
Conclusions TF-secreted Wnt2 acts as a growth and invasion-promoting factor through activating the canonical Wnt/b-catenin signalling pathway in oesophageal cancer cells.
Mounting evidence suggests that the tumour microenvironment, composed of non-cancer cells and their stroma, plays an important role in cancer development and progression. 1 2 Our previous study has described a broad range of deregulated genes between fibroblasts isolated from oesophageal squamous cell carcinoma (OSCC) and their adjacent non-tumorous oesophageal tissues. Approximately 43% (126/292) of known deregulated genes in tumour fibroblasts (TF) were associated with cell proliferation, extracellular matrix remodelling and immune response. 3 Notably, several members of the Wnt pathway, including WNT2, WNT5A, LEF1 and WISP1, were upregulated in TF, suggesting that Wnt signalling might be involved in the tumourestromal interactions in oesophageal cancer. 3 The Wnt proteins are secreted ligand proteins (approximately 40 kDa in size) that act in a paracrine fashion by activating diverse signalling cascades inside their target cells. The Wnt signalling pathway diversifies into three main branches. 4 The best understood is the so-called canonical pathway, which activates target genes through stabilisation of How might it impact on clinical practice in the foreseeable future?
< Based on our findings, future therapeutic targets for interfering with Wnt signalling include cell surface receptors and secreted signalling molecules, which mediate signalling between cancer cells and the stromal environment, and may serve as effective treatment approaches to patients with OSCC.
kinase C (known as the Wnt/Ca 2+ pathway), which involves an increase in intracellular calcium (Ca 2+ ), or Jun N-terminal kinase (known as the planar cell polarity pathway), which controls cytoskeletal rearrangements and cell polarity. The canonical Wnt pathway is the most prevalent Wnt signalling pathway in the development of cancer. The Wnt2 gene, located on chromosome 7q31.3, is highly expressed in fetal lungs and weakly expressed in the placenta. 5 Blasband et al 6 has reported that overexpression of Wnt2, with signalling through b-catenin, promotes transformation of mammary epithelial cells in the mouse cell line C57MG, demonstrating the oncogenic activity of Wnt2. As some Wnt ligands are stromally secreted with cognate receptors expressed by the epithelia, Wnt proteins are good candidates for mediating tumourestromal interactions. 7 8 Our previous study has identified WNT2 as one of the upregulated WNT genes in TF isolated from primary OSCC. In the present study, we further investigated the role of Wnt2 secreted by TF in OSCC tumourigenesis. Our results showed that Wnt2-positive expression was significantly correlated with poor clinical outcomes of OSCC patients. We also demonstrated that secreted Wnt2 acts as a growth and invasion-promoting factor through activating the canonical Wnt/b-catenin signalling pathway in oesophageal cancer cells.
MATERIALS AND METHODS Cell lines and primary tumour specimens
Two Chinese OSCC cell lines (EC18 and EC109) were kindly provided by Professor Tsao GS (Department of Anatomy, The University of Hong Kong). Five Japanese OSCC cell lines (KYSE30, KYSE140, KYSE180, KYSE410 and KYSE510) were obtained from DSMZ (Braunschweig, Germany), the German Resource Centre for Biological Material. 9 The Chinese hamster ovary cell line (CHO-K1) was purchased from the American Type Culture Collection (Manassas, Virginia, USA). Primary OSCC tissues and their adjacent normal oesophageal tissues were collected immediately after surgical resection in the Cancer Center of Sun Yat-sen University (Guangzhou, China). A total of 51 formalin-fixed and paraffin-embedded OSCC were also kindly provided by the Cancer Center of Sun Yat-sen University. The clinical data of patients included in this study are detailed in supplementary table S1 (available online only). All patients did not receive preoperative treatment. Clinical samples used in this study were approved by the Committee for Ethical Review of Research at Sun Yat-sen University.
Isolation of fibroblasts
TF and their matched normal fibroblasts were isolated from primary OSCC as described previously. 3 Briefly, freshly collected OSCC tumour tissue and its paired non-tumorous oesophageal tissue were cut into as small pieces as possible in sterile phosphate-buffered saline (PBS) solution, followed by collagenase digestion. The suspension was filtered through 20 mm stainless steel wire mesh to collect a single cell suspension. The filtrate was centrifuged and washed before being finally plated on 6 cm tissue culture dishes in 5 ml DMEM medium supplemented with 20% fetal bovine serum (FBS). After culturing for 30 min at 378C, unadherent cells (mainly tumour cells) were removed to obtain pure fibroblasts. The adherent fibroblasts were subcultured for further study.
Plasmid construction and transfection
The WNT2 gene was PCR amplified, cloned into pcDNA3.1/V5-His TOPO TA vector (Invitrogen, Carlsbad, California, USA), and transfected into CHO cells using Lipofectamine 2000 (Invitrogen), following the manufacturer's instructions. Stably Wnt2-expressing clones (CHO-Wnt2) were screened. CHO cells transfected with the empty pcDNA3.1 vector (CHO-Vec) were used as control.
Conditioned medium
Stably Wnt2-expressing cells (CHO-Wnt2) and empty vector transfected cells (CHO-Vec) were cultured in DMEM medium with 10% FBS until 70% confluence. After complete removal of the normal culture medium, CHO-Wnt2 and CHO-Vec cells were continually cultured in DMEM medium with 3% FBS for 24 h before medium collection. Culture medium was then centrifuged at 1000 g for 30 min and the supernatant was collected as conditioned medium for further study.
Quantitative and semiquantitative RTePCR
Total RNA was extracted by Trizol (Invitrogen). Two micrograms of total RNA was used to synthesise complimentary DNA with the Advantage RT-for-PCR Kit (Clontech Laboratories, Inc, Mountain View, California, USA), following the standard protocols provided by the manufacturer. Semiquantitative reverse transcriptase (RT)ePCR was performed by using AmpliTaq (Applied Biosystems, Foster City, California, USA). GAPDH was used as a control. For quantitative real-time PCR (qPCR), cDNA products were amplified using a SYBR Green PCR Kit (Applied Biosystems). The amplification protocol consisted of incubations at 958C for 15 s, 608C for 1 min and 728C for 1 min for 40 cycles. Quantification was done using the ABI PRISM 7900HT sequence detection system (Applied Biosystems). All gene expression values were normalised using the housekeeping genes GAPDH and calculated using the comparative C T method (DD C T method). 3 
Immunohistochemical staining
Immunohistochemical staininh was performed using a standard streptavidinebiotineperoxidase complex method. In brief, paraffin block sections of oesophageal cancers were deparaffinised, blocked with 10% normal rabbit serum for 10 min, and incubated with rabbit anti-human Wnt2 polyclonal antibody (MBL, 1:150 dilution) overnight at 48C. The slides were then incubated with biotinylated goat anti-rabbit immunoglobulin at a concentration of 1:100 at 378C for 30 min. The status of the cytoplasmic expression of Wnt2 was assessed by three independent investigators without previous knowledge of clinicopathological data. Positive expression of Wnt2, primarily a cytoplasmic pattern, was mostly detected in the stromal compartment within tumour tissue. In the present study, a positive result was defined when five or more Wnt2-positive cells were detected per microscopy field (203 in magnification).
Immunofluorescence
Cells cultured with conditioned medium from Wnt2-expressing CHO cells and control cells were grown on gelatin-coated coverslips for the indicated time points and then fixed in 4% p-formaldehyde at room temperature for 20 min. Cells were incubated with PBS-B solution at 378C for 30 min to block nonspecific interactions and stained with anti-b-catenin mouse monoclonal antibody (Immunofluorescence (IF) Preferred; Cell Signalling Technology, Danvers, Massachusetts, USA) at 48C overnight. After several washes in PBS, cells were incubated with optimal concentrations of FITC-labelled goat anti-mouse secondary antibody (eBioscience, San Diego, California, USA) at room temperature for 1 h. Anti-fade DAPI solution was added and images were obtained. For immunofluorescence double-labelling, paraffin block sections of oesophageal cancers were incubated with a mouse antibody against vimentin and a rabbit antibody against Wnt2 simultaneously at 378C overnight. After brief washing, slides were incubated with FITC goat anti-mouse (eBioscience) and Texas-red goat anti-rabbit (eBioscience) secondary antibodies at room temperature for 1 h. After brief washing, slides were counterstained with DAPI in anti-fade solution.
Cell proliferation assay
To test the effect of Wnt2 secretion on cell growth rate, KYSE30 and EC109 cells were seeded onto 96-well plates at a density of 2310 3 per well. After 24-h incubation, normal growth media was replaced by conditioned medium from Wnt2-expressing clones and control cells. The cell growth rate was detected using the cell proliferation XTT kit (Sigma, St Louis, Missouri, USA) according to the manufacturer 's instruction.
Migration and invasion assays
For cell migration assay, KYSE30 and EC109 cells were grown to confluence and then mechanically scratched with a sterile pipette tip. Cells were rinsed with PBS and grown in CHO-Wnt2 conditioned medium and CHO-Vec conditioned medium for an additional 72 h. The cell motility in terms of wound closure was measured by photographing at three random fields at time points 0 and 72 h. For invasion assay, KYSE30 and EC109 cells were starved with serum-free medium for 24 h before the assay. Cells (5310 4 ) were suspended in 0.5 ml serum-free medium and loaded on the upper compartment of the invasion chamber coated with Matrigel (BD Biosciences, Franklin Lakes, NJ, USA). The lower compartment was filled with CHO-Wnt2 conditioned medium and CHO-Vec conditioned medium as chemoattractant. After 48 h, invasive cells were fixed, stained and counted under a microscope. Three independent experiments were done with triplicates each time for both migration and invasion assays.
Western blotting analysis
Western blotting was done according to the standard protocol with antibodies for rabbit anti-Wnt2 (R&D Systems, Minneapolis, Minnesota, USA; 1:400), rabbit anti-cyclin D1, -c-myc, a-catenin, and b-catenin (Cell Signalling Technology; 1:1000), and mouse anti-E-cadherin, a-SMA, -Vimentin and b-actin 
Statistical analysis
Statistical analysis was performed using SPSS standard V.13.0 software. Data are expressed as mean6SD from at least three independent determinations. Significance of difference was analysed using Student's t tests. The correlation between Wnt2 expression and clinicopathological characteristics was analysed using Fisher's exact test. Disease-specific survival was calculated from the date of diagnosis to the date of cancer-related death or last follow-up. Survival curves was assessed by the KaplaneMeier method and compared by the log-rank test. Differences were considered significant for p<0.05.
RESULTS

Wnt2 is overexpressed mainly in OSCC TF
qPCR was used to compare WNT2 expression status between TF and normal fibroblasts isolated from 10 primary OSCC. Consistent with our previous finding, 3 WNT2 expression was approximately fourfold higher in the TF than the normal fibroblasts ( figure 1A ). Statistical analysis showed that the difference in WNT2 expression was significant (p<0.05, independent Student's t test) between normal fibroblasts and TF. Western blot analysis confirmed that the expression of Wnt2 protein was also higher in TF than that in normal fibroblasts (figure 1B). Interestingly, no visible protein expression of Wnt2 was detected in all tested OSCC cancer cell lines (figure 1C).
Distribution of Wnt2-positive cells in primary OSCC
To study further the distribution of Wnt2(+) cells in OSCC, immunohistochemical staining was used to detect Wnt2 expression cells in 51 primary OSCC cases. Wnt2(+) cells were almost undetectable in adjacent non-tumorous oesophageal tissue ( figure 2A) . In OSCC tissues, Wnt2(+) cells could be detected in 42/51 (82.4%) cases. Wnt2(+) cells were mainly detected in the boundary between stroma and tumour tissue, stroma between tumour nests and scattered within tumour tissue ( figure 2A) . Two-colour (green vimentin; red Wnt2) staining immunofluorescence confirmed that Wnt2 and vimentin were co-expressed in the same cells, suggesting that Wnt2(+) cells were fibroblasts ( figure 2B,C) . Wnt2-positive OSCC, which was defined when five or more Wnt2(+) cells were observed in 2003 microscopy field, was detected in 22/51 (43.1%) of OSCC in the present study.
The correlation of Wnt2-positive expression with OSCC prognosis
Correlation of the Wnt2-positive expression with clinicopathological features was studied in 51 OSCC. The results found that Wnt2(+) OSCC was significantly associated with TNM stage (p¼0.001, Fisher's exact test) and lymph node metastasis (p¼0.001, Fisher's exact test; table 1). Furthermore, the log rank test showed that the disease-specific survival of OSCC with Wnt2(+) OSCC (median survival time, 16 months) was significantly shorter than patients with Wnt2(À) OSCC (median survival time, 51 months; p<0.0001; figure 3 ).
Establishment of secreted Wnt2 conditioned medium
To investigate further the effect of secreted Wnt2 on OSCC cells, an in-vitro Wnt2 secreting system was established using CHO cells. Briefly, Wnt2 expression plasmid was stably transfected into CHO cells (CHO-Wnt2), and empty vector-transfected CHO cells (CHO-Vec) were used as controls. After a short culture (24 h) in 3% FBS, culture medium was collected as conditioned medium for further study ( figure 4A ). The ecpotic expression of Wnt2 in CHO cells was confirmed at both messenger RNA and protein (figure 4B) levels. Secreted Wnt2 was also detected in the conditioned medium collected from CHO-Wnt2 cells (figure 4B).
Secreted Wnt2 promotes cell proliferation in OSCC cells
To analyse the effect of Wnt2 on cell proliferation, OSCC cell lines (KYSE30 or EC109) were incubated in DMEM medium with 10% FBS, conditioned medium from CHO-Wnt2 or CHOVec cells, respectively, for 4 days. Cell proliferation (XTT) assay showed that the cell growth rate was significantly higher (p<0.001) in cells cultured with conditioned medium from CHO-Wnt2 than that of cells cultured with conditioned medium from CHO-Vec ( figure 4C,D) .
Wnt2 promotes cell proliferation via nuclear translocation of b-catenin
In an attempt to explore the potential molecular mechanism of the proliferating promotion effect of secreted Wnt2 on OSCC, the Wnt/b-catenin signalling pathway in KYSE30 and EC109 cells was characterised. Immunofluorescence was used to visualise the localisation of b-catenin at different time points (0, 1, 2 and 6 h) after Wnt2-conditioned medium incubation. As shown in figure 5A , b-catenin was mainly localised on the membrane of KYSE30 cells before incubation with the CHO-Wnt2 conditioned medium (CHO-Wnt2 conditioned medium). After incubation with CHO-Wnt2 conditioned medium for 1 h, 
Wnt2 enhances cell motility and invasiveness via epithelialemesenchymal transition
As our correlation study showed that the positive expression of Wnt2 was closely associated with OSCC metastasis, the metastatic role of Wnt2 was studied by wound-healing and invasion assays. In the wound-healing assay, no significant difference was observed between CHO-Vec and CHO-Wnt2 conditioned medium cultured KYSE30 or EC109 cells over a 24-h incubation.
As shown in figure 7A , CHO-Wnt2 conditioned medium could dramatically enhance cell migration ability in OSCC cells at 72 h after incubation, compared with control conditioned medium (p<0.05). Subsequently, we measured the capacity of OSCC cells to invade through matrigel, an artificial extracellular matrix, after incubation with CHO-Wnt2 conditioned medium or control conditioned medium. KYSE30 and EC109 cells cultured with CHO-Wnt2 conditioned medium showed an increased invasion by 53% and 75%, respectively (p<0.01; figure 7B ). To determine whether the effect of Wnt2 on cell migration and invasion was associated with epithelialemesenchymal transition, expressions of several epithelial markers (a-catenin, b-catenin and E-cadherin) and mesenchymal markers (a-SMA and vimentin) were compared between CHO-Wnt2 conditioned medium and control conditioned medium cultured OSCC cells at the 6-h time point by western blot analysis. Except for the absent expression of E-cadherin in EC109 cells, the results showed that the expression of all the tested epithelial markers was significantly downregulated, whereas the mesenchymal markers were upregulated in CHO-Wnt2 conditioned medium cultured KYSE30 and EC109 cells ( figure 7C ). These findings indicated that Wnt2 increased cell migration and invasion was through epithelialemesenchymal transition.
DISCUSSION
The role of the Wnt signalling pathway in normal development and organogenesis has been widely investigated in recent years.
10e13 An aberrantly activated Wnt signalling pathway may lead to the development of cancer. 14 15 Among members of the human WNT gene family, WNT2 has been reported as a protooncogene with the potential to activate the WNT/b-catenin signalling pathway. Upregulation of Wnt2 has been detected in colorectal cancer, 16 gastric cancer 17 and oesophageal adenocarcinoma. 18 In the present study, we found that Wnt2 was seldom expressed in OSCC tumour cells. However, Wnt2(+) cells could be detected in 82.4% of primary OSCC cases, mainly distributed in the boundary between tumour and its surrounding stroma tissues, or in the stroma tissue between tumour nests, or scattered within tumour tissue. This distribution pattern is similar to that of FGFR2(+) cells, which have been shown to be TF in our previous study. 3 An immunofluorescence study with antibodies to Wnt2 and the fibroblast marker vimentin showed that Wnt2 and vimentin were co-expressed in the same cells, suggesting that Wnt2(+) cells were TF. In addition, OSCC patients with more Wnt2(+) cells in OSCC tissue had shorter survival times, and the association was significant (p<0.0001). These data suggest that Wnt2 might play an important role in the development and progression of OSCC.
To investigate the effect of TF-secreted Wnt2 on oesophageal cancer cell growth, we established an in-vitro Wnt2 secretion system. The conditional medium collected from cultured CHOWnt2 cells, which contains secreted human Wnt2, could promote cell growth. This finding suggests that Wnt2 secreted by TF can modulate the growth of cancer cells during tumour development. In the present study, we found that secreted Wnt2 could activate the canonical Wnt signalling pathway, which was characterised by b-catenin accumulation in the cytoplasm, translocation into the nucleus and activation of transcription of Wnt target genes including MYC and CCND1. Our results clearly showed that b-catenin was accumulated in the cytoplasm at 1 h and entered into the nucleus at 2 h after oesophageal cancer cells treated with CHO-Wnt2 conditioned media, suggesting that the presence of Wnt2 in the conditioned media successfully activated the canonical Wnt signalling pathway.
Interestingly, nuclear b-catenin was declined while membranous b-catenin was increased after 6 h of incubation with CHOWnt2 conditioned medium, resulting in a decrease of c-myc and cyclin D1 compared with those seen at 2 h and 4 h. It has also been reported that Wnt-1 conditioned media led to an accumulation of cytoplasmic b-catenin in OSCC cells at 1.5 h and sustained until 4 h after incubation. 21 Taken together, these findings suggest that secreted Wnt2 may act as an initiating factor during the stromaleepithelial interaction. However, the subsequent crosstalk between the Wnt2-mediated signalling pathway and other signalling networks, which contribute to cancer cell proliferation, need to be investigated further.
As a key component of the Wnt signalling pathway, b-catenin has been implicated in many human cancers, 22 and its oncogenic potential has been extensively studied in in-vitro tissue culture models 23 24 and in-vivo animal models. Another interesting finding of this study is the promoting effect of Wnt2 on tumour metastasis in OSCC. Our data showed that exogenous Wnt2 could promote cell motility and invasiveness of OSCC cells in vitro. This mirrored the findings of Wnt2(+) OSCC was significantly associated with advanced clinical stage and lymph node metastasis. Increasing attention towards the role of epithelialemesenchymal transition as a critical component of metastasis 37 has been thought to underlie the spread of malignant cells from a primary carcinoma to distant sites. 38 Several studies suggest that the Wnt/b-catenin signal pathway may play an important role in epitheliale mesenchymal transition. Indeed, our results showed that b-catenin entered into the nucleus at 2 h and removed from the nucleus to membrane at 6 h with the presence of Wnt2. Furthermore, we detected the decreased total protein level of b-catenin at 6 h after incubation with Wnt2, accompanied by the decreased expression of a-catenin and E-cadherin and increased expression of a-SMA and vimentin. These results strongly suggested that the Wnt2eb-catenine epithelialemesenchymal transition pathway may play a critical role in OSCC progression.
In summary, we report that TF-secreted Wnt2 acts in a paracrine manner in oesophageal cancer initiation and progression by activating the canonical Wnt/b-catenin signalling pathway. Despite the importance of tumourestromal interactions, our knowledge of the genes that mediate changes in the tumour microenvironment and tumourestromal interactions in oesophageal cancer is still limited. Based on our findings, future therapeutic targets for interfering with Wnt signalling include cell surface receptors and secreted signalling molecules, which mediate signalling between cancer cells and the stromal environment, and may serve as effective treatment approaches to OSCC patients.
